|
|||||
|
 | |
| |
| |
| |
| |
| |
|
Gene: TERF2 |
Gene summary for TERF2 |
 Gene summary. |
| Gene information | Species | Human | Gene symbol | TERF2 | Gene ID | 7014 |
| Gene name | telomeric repeat binding factor 2 | |
| Gene Alias | TRBF2 | |
| Cytomap | 16q22.1 | |
| Gene Type | protein-coding | GO ID | GO:0000012 | UniProtAcc | Q15554 |
Top |
Malignant transformation analysis |
| Identification of the aberrant gene expression in precancerous and cancerous lesions by comparing the gene expression of stem-like cells in diseased tissues with normal stem cells |
| Malignant transformation involving gene list. |
| Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
| 7014 | TERF2 | HTA11_3361_2000001011 | Human | Colorectum | AD | 2.61e-03 | 5.02e-01 | -0.1207 |
| 7014 | TERF2 | HTA11_7663_2000001011 | Human | Colorectum | SER | 6.87e-07 | 1.04e+00 | 0.0131 |
| 7014 | TERF2 | A015-C-203 | Human | Colorectum | FAP | 3.93e-06 | -1.60e-01 | -0.1294 |
| 7014 | TERF2 | A002-C-201 | Human | Colorectum | FAP | 4.26e-03 | -1.69e-01 | 0.0324 |
| 7014 | TERF2 | A002-C-203 | Human | Colorectum | FAP | 2.05e-04 | -1.70e-01 | 0.2786 |
| 7014 | TERF2 | A001-C-108 | Human | Colorectum | FAP | 4.16e-04 | -1.15e-01 | -0.0272 |
| 7014 | TERF2 | A002-C-205 | Human | Colorectum | FAP | 1.94e-05 | -1.66e-01 | -0.1236 |
| 7014 | TERF2 | A015-C-006 | Human | Colorectum | FAP | 9.31e-04 | -1.75e-01 | -0.0994 |
| 7014 | TERF2 | A002-C-114 | Human | Colorectum | FAP | 2.35e-04 | -1.87e-01 | -0.1561 |
| 7014 | TERF2 | A015-C-104 | Human | Colorectum | FAP | 2.65e-08 | -1.33e-01 | -0.1899 |
| 7014 | TERF2 | A001-C-014 | Human | Colorectum | FAP | 5.24e-07 | -2.30e-01 | 0.0135 |
| 7014 | TERF2 | A002-C-016 | Human | Colorectum | FAP | 3.23e-06 | -2.17e-01 | 0.0521 |
| 7014 | TERF2 | A002-C-116 | Human | Colorectum | FAP | 1.62e-07 | -1.91e-01 | -0.0452 |
| 7014 | TERF2 | A014-C-008 | Human | Colorectum | FAP | 7.14e-03 | -1.98e-01 | -0.191 |
| 7014 | TERF2 | A018-E-020 | Human | Colorectum | FAP | 3.68e-05 | -1.94e-01 | -0.2034 |
| 7014 | TERF2 | F034 | Human | Colorectum | FAP | 1.39e-05 | -2.06e-01 | -0.0665 |
| 7014 | TERF2 | F072B | Human | Colorectum | FAP | 2.88e-03 | -1.69e-01 | 0.257 |
| 7014 | TERF2 | CRC-1-8810 | Human | Colorectum | CRC | 2.34e-02 | -1.45e-01 | 0.6257 |
| 7014 | TERF2 | GSM6177620_NYU_UCEC1_lib3_lib3 | Human | Endometrium | EEC | 4.26e-04 | 6.19e-02 | -0.1883 |
| 7014 | TERF2 | GSM6177622_NYU_UCEC3_lib2_lib2 | Human | Endometrium | EEC | 2.42e-03 | -1.31e-03 | -0.1916 |
| Page: 1 2 |
| Transcriptomic changes along malignancy continuum. |
| Tissue | Expression Dynamics | Abbreviation |
| Colorectum (GSE201348) |  | FAP: Familial adenomatous polyposis |
| CRC: Colorectal cancer | ||
| Colorectum (HTA11) |  | AD: Adenomas |
| SER: Sessile serrated lesions | ||
| MSI-H: Microsatellite-high colorectal cancer | ||
| MSS: Microsatellite stable colorectal cancer | ||
| Endometrium |  | AEH: Atypical endometrial hyperplasia |
| EEC: Endometrioid Cancer | ||
| Thyroid |  | ATC: Anaplastic thyroid cancer |
| HT: Hashimoto's thyroiditis | ||
| PTC: Papillary thyroid cancer |
| ∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
| Find out the enriched GO biological processes and KEGG pathways involved in transition from healthy to precancer to cancer |
| Figure of enriched GO biological processes. |
| Tissue | Disease Stage | Enriched GO biological Processes |
| Colorectum | AD |  |
| Colorectum | SER |  |
| Colorectum | MSS |  |
| Colorectum | MSI-H |  |
| Colorectum | FAP |  |
| ∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
| Page: 1 2 3 4 5 6 7 8 9 |
| Enriched GO biological processes. |
| GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
| GO:004312320 | Thyroid | PTC | positive regulation of I-kappaB kinase/NF-kappaB signaling | 91/5968 | 186/18723 | 8.76e-07 | 1.33e-05 | 91 |
| GO:00701989 | Thyroid | PTC | protein localization to chromosome, telomeric region | 22/5968 | 29/18723 | 1.44e-06 | 2.04e-05 | 22 |
| GO:00457867 | Thyroid | PTC | negative regulation of cell cycle | 166/5968 | 385/18723 | 1.93e-06 | 2.64e-05 | 166 |
| GO:000756917 | Thyroid | PTC | cell aging | 68/5968 | 132/18723 | 2.09e-06 | 2.84e-05 | 68 |
| GO:0010833111 | Thyroid | PTC | telomere maintenance via telomere lengthening | 46/5968 | 81/18723 | 3.10e-06 | 4.04e-05 | 46 |
| GO:0006278110 | Thyroid | PTC | RNA-dependent DNA biosynthetic process | 43/5968 | 75/18723 | 4.61e-06 | 5.66e-05 | 43 |
| GO:003221010 | Thyroid | PTC | regulation of telomere maintenance via telomerase | 33/5968 | 53/18723 | 5.10e-06 | 6.20e-05 | 33 |
| GO:190435619 | Thyroid | PTC | regulation of telomere maintenance via telomere lengthening | 36/5968 | 61/18723 | 1.11e-05 | 1.22e-04 | 36 |
| GO:00062828 | Thyroid | PTC | regulation of DNA repair | 65/5968 | 130/18723 | 1.25e-05 | 1.36e-04 | 65 |
| GO:2000278112 | Thyroid | PTC | regulation of DNA biosynthetic process | 55/5968 | 106/18723 | 1.45e-05 | 1.55e-04 | 55 |
| GO:00991115 | Thyroid | PTC | microtubule-based transport | 88/5968 | 190/18723 | 2.08e-05 | 2.08e-04 | 88 |
| GO:20010216 | Thyroid | PTC | negative regulation of response to DNA damage stimulus | 44/5968 | 81/18723 | 2.34e-05 | 2.33e-04 | 44 |
| GO:00062606 | Thyroid | PTC | DNA replication | 114/5968 | 260/18723 | 3.09e-05 | 2.95e-04 | 114 |
| GO:00322009 | Thyroid | PTC | telomere organization | 74/5968 | 159/18723 | 7.46e-05 | 6.43e-04 | 74 |
| GO:005109016 | Thyroid | PTC | regulation of DNA-binding transcription factor activity | 178/5968 | 440/18723 | 7.63e-05 | 6.54e-04 | 178 |
| GO:0071897110 | Thyroid | PTC | DNA biosynthetic process | 82/5968 | 180/18723 | 7.98e-05 | 6.81e-04 | 82 |
| GO:00903986 | Thyroid | PTC | cellular senescence | 47/5968 | 93/18723 | 1.37e-04 | 1.07e-03 | 47 |
| GO:190122415 | Thyroid | PTC | positive regulation of NIK/NF-kappaB signaling | 37/5968 | 69/18723 | 1.46e-04 | 1.13e-03 | 37 |
| GO:000808819 | Thyroid | PTC | axo-dendritic transport | 39/5968 | 75/18723 | 2.31e-04 | 1.67e-03 | 39 |
| GO:19019852 | Thyroid | PTC | positive regulation of protein acetylation | 26/5968 | 45/18723 | 2.94e-04 | 2.08e-03 | 26 |
| Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 |
| Enriched KEGG pathways. |
| Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
| Page: 1 |
Top |
Cell-cell communication analysis |
| Identification of potential cell-cell interactions between two cell types and their ligand-receptor pairs for different disease states |
| Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
| Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
| Find out the significant the regulons (TFs) and the target genes of each regulon across cell types for different disease states |
| TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
| ∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
| Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
| Annotation of somatic variants for genes involved in malignant transformation |
| Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
| TERF2 | SNV | Missense_Mutation | c.1005N>C | p.Lys335Asn | p.K335N | Q15554 | protein_coding | tolerated(0.05) | benign(0.196) | TCGA-E2-A1LH-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | adriamycin | SD | |
| TERF2 | insertion | Nonsense_Mutation | novel | c.978_979insGGCTGAGGCAGGCAGATTACCTG | p.Met327GlyfsTer2 | p.M327Gfs*2 | Q15554 | protein_coding | TCGA-BH-A0AY-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | SD | |||
| TERF2 | insertion | Frame_Shift_Ins | novel | c.666dupA | p.His223ThrfsTer14 | p.H223Tfs*14 | Q15554 | protein_coding | TCGA-2W-A8YY-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR | ||
| TERF2 | SNV | Missense_Mutation | novel | c.851A>C | p.Lys284Thr | p.K284T | Q15554 | protein_coding | deleterious(0.03) | possibly_damaging(0.864) | TCGA-5M-AAT6-01 | Colorectum | colon adenocarcinoma | Female | <65 | III/IV | Unknown | Unknown | PD |
| TERF2 | SNV | Missense_Mutation | c.1365C>A | p.Ser455Arg | p.S455R | Q15554 | protein_coding | deleterious(0.02) | benign(0.343) | TCGA-AD-5900-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | |
| TERF2 | SNV | Missense_Mutation | c.701N>T | p.Arg234Ile | p.R234I | Q15554 | protein_coding | deleterious(0) | probably_damaging(0.927) | TCGA-AG-A002-01 | Colorectum | rectum adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD | |
| TERF2 | SNV | Missense_Mutation | c.1336C>T | p.Pro446Ser | p.P446S | Q15554 | protein_coding | tolerated(0.3) | benign(0.185) | TCGA-EI-6513-01 | Colorectum | rectum adenocarcinoma | Male | <65 | III/IV | Unknown | Unknown | SD | |
| TERF2 | SNV | Missense_Mutation | novel | c.727N>A | p.Glu243Lys | p.E243K | Q15554 | protein_coding | deleterious(0) | benign(0.036) | TCGA-EI-6917-01 | Colorectum | rectum adenocarcinoma | Male | <65 | III/IV | Chemotherapy | 5fluorouracil+oxaciplatina+l-folinian | SD |
| TERF2 | SNV | Missense_Mutation | c.968C>T | p.Thr323Ile | p.T323I | Q15554 | protein_coding | deleterious(0) | benign(0.011) | TCGA-G5-6641-01 | Colorectum | rectum adenocarcinoma | Male | >=65 | III/IV | Chemotherapy | oxaliplatin | SD | |
| TERF2 | deletion | Frame_Shift_Del | c.259delG | p.Glu87ArgfsTer72 | p.E87Rfs*72 | Q15554 | protein_coding | TCGA-NH-A5IV-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
| Page: 1 2 3 4 5 |
Top |
Related drugs of malignant transformation related genes |
| Identification of chemicals and drugs interact with genes involved in malignant transfromation |
| (DGIdb 4.0) |
| Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
| Page: 1 |
Copyright 2023-Present -The University of Texas Health Science Center at Houston |